Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

Kenvue said Monday that its board was taking steps to realize shareholder value and allow the company to “reach its full ...

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Perry is a current Kenvue director and seasoned consumer products and brand strategist with more than 30 years of experience.

Kenvue, the Johnson & Johnson spinoff that owns brands such as Tylenol and Benadryl, announced Monday that Chief Executive ...

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

Kenvue chief executive officer, Thibaut Mongon, has stepped down from the role and the company's board amid an ongoing ...

Diageo CEO Debra Crew has stepped down after two years in the job, the world's biggest spirits maker said on Wednesday, with finance chief Nik Jhangiani taking over in the interim as the company ...

Other perks Bender will enjoy as interim CEO is a monthly stipend of $11,500 to cover “any personal commuting expenses” while working at the company’s Menomonee Falls headquarters and use of ...

Current Kenvue Director, Kirk Perry, is named Interim CEO, effective immediately. Kenvue Board of Directors appointed a new Interim CEO and is advancing an ongoing comprehensive review of strategic ...